A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
Clinical trial NCT06052059 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06052059
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-25
- Primary completion
- 2026-08-01
- Enrollment
- 1020
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.